Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
International Journal of Pharmaceutical Compounding|December 16, 2025
Personalized Orodispersible Films Compounded with OrPhyllo™ Ready-to-use Base: API Compatibility and Evidence-Based Beyond-Use DatesCarolina Schettino Kegele, Bruna Marianni, Hudson Polonini
International Journal of Pharmaceutical Compounding|December 16, 2025
Evidence-Based Beyond-Use Dates for Pentravan® Compounded Formulations in Hormone Therapy and Pain ManagementHudson Polonini, Carolina Schettino Kegele, Bruna Marianni
International Journal of Pharmaceutical Compounding|February 8, 2025
Compatibility of 17-a-estradiol, Caffeine, Clobetasol Propionate, Finasteride Melatonin, Metronidazole, Spironolactone, Tretinoin, and Triamcinolone in Trichosol, a Natural Vehicle for Hair SolutionsCarolina Schettino Kegele, Bruna Marianni, Hudson Polonini
International Journal of Pharmaceutical Compounding|September 17, 2025
Antimicrobial Effectiveness and Physicochemical Stability of Compounded Psychiatric and Neurological Drug Suspensions in SyrSpend® SF PH4Carolina Schettino Kegele, Eli Dijkers, Hudson Polonini
International Journal of Pharmaceutical Compounding|October 20, 2025
SyrSpend® SF PH 4 as a Safe Vehicle for Extemporaneous Oral Suspensions: Microbiological Stability of Seven APIsCarolina Schettino Kegele, Eli Dijkers, Hudson Polonini
International Journal of Pharmaceutical Compounding|October 20, 2025
Microbiological and Physical Stability of Extemporaneous Oral Suspensions Compounded with SyrSpend® SF PH4Carolina Schettino Kegele, Eli Dijkers, Hudson Polonini
International Journal of Pharmaceutical Compounding|September 17, 2025
Antimicrobial Stability, pH, and Physical Appearance of Cardiovascular Drug Suspensions in SyrSpend® SF PH4: A Complementary EvaluationCarolina Schettino Kegele, Eli Dijkers, Hudson Polonini
International Journal of Pharmaceutical Compounding|June 29, 2025
Physicochemical and Microbiological Stability of Commonly Prescribed APIs in SyrSpend® SF PH4: A Comprehensive Compatibility StudyCarolina Schettino Kegele, Eli Dijkers, Hudson Polonini
International Journal of Pharmaceutical Compounding|May 17, 2026
Chemical and Microbiological Stability Supporting Extended BUDs in Pentravan® Based Transdermal PreparationsHudson Polonini, Carolina Schettino Kegele, Bruna Marianni
International Journal of Pharmaceutical Compounding|June 29, 2025
Personalized Compounded Hair Loss Treatments: A Compatibility Assessment of the TrichoConcept™ Vehicle LineCarolina Schettino Kegele, Bruna Marianni, Hudson Caetano Polonini
Pageof 2